Clinical trials
Intractable Pain trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 7 |
| Recruiting | 4 |
| Suspended | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 4 |
| Abbott Medical Devices | 3 |
| Flowonix Medical | 2 |
| MedtronicNeuro | 2 |
| Rush University Medical Center | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Vanderbilt University Medical Center | 2 |
| Bux, Anjum, MD | 1 |
| Children's Hospital of Philadelphia | 1 |
| Diamyd Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intractable Pain | 38 |
| Chronic Pain | 20 |
| Back Pain | 11 |
| Pain | 8 |
| Neuralgia | 6 |
| Agnosia | 5 |
| Cancer Pain | 4 |
| Neoplasms | 4 |
| Failed Back Surgery Syndrome | 3 |
| Low Back Pain | 3 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.